my account log out | |
Anti-CA19-9 x Anti-CD3 Bispecific Antibody (IgG-IgG) |
Create: 07/31/2019 |
Expired Date: | never |
Category: | Cell size analyzers [Health&Medical&Pharmaceutical] |
Message: | Anti-CA19-9 x Anti-CD3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CA19-9 and anti-CD3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Ovarian cancer; Pancreatic cancer; Gastric cancer therapy.https://www.creative-biolabs.com/bsab/symbolsearch-ca19-9%2520%2526%2520cd3.htm |
City: | New York[US] |
Location: | |
Mar 06 2023 | Rat Wistar Complement Serum | 217 | |
Mar 06 2023 | Rat Sprague Dawley Complement Serum | 220 | |
Mar 06 2023 | Sheep Complement Serum | 214 | |
Mar 06 2023 | Monkey Rhesus Complement Serum | 225 | |
Mar 06 2023 | Rabbit Complement Serum | 221 | |
Mar 06 2023 | Porcine Complement Serum | 222 | |
Mar 06 2023 | Hamster Syrian Gold Complement Serum | 219 | |
Mar 06 2023 | Hamster Armenian Complement Serum | 209 | |
Mar 06 2023 | Goat Complement Serum | 214 | |
Mar 06 2023 | Monkey Cynomolgus Complement Serum | 206 |
Copyright © toextrade Inc. All rights reserved. Contact us |